跳至主要内容
临床试验/NCT06233760
NCT06233760招募中不适用

Prevalence of Abuse Among Patients With Rheumatic Diseases

National Institute of Medical Sciences and Nutrition, Salvador Zubiran1 个研究点 分布在 1 个国家目标入组 244 人开始时间: 2023年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
244
试验地点
1
主要终点
Number of Mexican patients with RD who will present the phenomenon of mistreatment

研究概览

简要总结

Patients with rheumatic diseases (RD) have a relevant representation in the adult population in Mexico. RD are characterized by their chronic and progressive nature, which can impact functionality during the disease and can present various factors that can be associated with the presence of abuse, among others, economic dependence, decreased physical capacity, and need for care and support in different health processes.

Regarding abuse in patients with RD, there is little information in the literature; however, it is possible that the prevalence could be similar to that of the occurrence in older adults since both populations share important states of vulnerability.

The study aimed to identify the prevalence of abuse in patients with RD. The study will be conducted in two phases: the first one in which the GAS will be adapted for patients with RD, and this version will be validated in a population of our Institute, and the second one in which, applying the validated instrument, the magnitude of abuse is evaluated, and the factors associated with this phenomenon among patients with RD are explored.

详细描述

Patients with rheumatic diseases (RD) have a relevant representation in the adult population in Mexico. RD are characterized by their chronic and progressive nature, which can impact functionality during the disease and can present various factors that can be associated with the presence of abuse, among others, economic dependence, decreased physical capacity, and need for care and support in different health processes.

In 1970, the phenomenon of abuse in geriatric patients was described for the first time as a phenomenon identified as a public health problem and an issue of human rights violation.

In 2012 Giraldo-Rodríguez developed and validated the Geriatric Abuse Scale (GAS), an instrument that, with adequate psychometric properties, reported a prevalence of abuse of 10.28% in Mexico.

Regarding abuse in patients with RD, there is little information in the literature; however, it is possible that the prevalence could be similar to that of the occurrence in older adults since both populations share important states of vulnerability.

The study aimed to identify the prevalence of abuse in patients with RD. The study will be conducted in two phases: the first one in which the GAS will be adapted for patients with RD, and this version will be validated in a population of our Institute, and the second one in which, applying the validated instrument, the magnitude of abuse is evaluated, and the factors associated with this phenomenon among patients with RD are explored.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a rheumatic disease diagnosis according to their primary rheumatologist who agree to participate

排除标准

  • Patients with a not confirmed rheumatic disease

结局指标

主要结局

Number of Mexican patients with RD who will present the phenomenon of mistreatment

时间窗: At inclusion (baseline moment) (cross-sectional study)

Identify the percentage of patients with rheumatic diseases that present mistreatment using the instrument developed by Giraldo-Rodríguez et al (translation, cultural adaptation, and validation performed)

次要结局

  • Identify factors associated with mistreatment among patients with rheumatic diseases(At inclusion (baseline moment) (cross-sectional study))

研究者

发起方
National Institute of Medical Sciences and Nutrition, Salvador Zubiran
申办方类型
Other
责任方
Principal Investigator
主要研究者

Virginia Pascual Ramos

Principal investigator

National Institute of Medical Sciences and Nutrition, Salvador Zubiran

研究点 (1)

Loading locations...

相似试验